• RT-PCR-based diagnostic solutions for HIV, TB, leukemia, and other infectious diseases
• AI-integrated cervical cancer detection for early and accurate diagnosis
• Multiplex PCR kits for drug-resistant TB (MDR-TB) and other pathogens
• AI-powered cervical cancer screening and staging systems
• Machine learning-based disease prediction and risk assessment
• AI-enhanced clinical decision support systems for healthcare providers
• Next-Generation Sequencing (NGS) for personalized medicine projects
• Genomic profiling for cancer, rare diseases, and inherited disorders
• Pharmacogenomics for targeted therapy selection
• Molecular epidemiology studies for emerging and re-emerging infectious diseases
• Surveillance programs for HIV, TB, and antimicrobial resistance (AMR)
• Collaboration with public health organizations for disease control initiatives
• Consulting for IVD (In Vitro Diagnostics) Molecular Diagnostics, Virology and Genomics and Infectious Disease
• Market research analytics for biotech start-ups and Life science companies.
• Assistance in obtaining NABL, and CE certifications for medical devices and diagnostics
• High-throughput molecular testing for hospitals, diagnostic labs, and research institutions for Oncology services (Haematological malignancy tests for AML-CML MPN and MDS and solid tumours (NSCLC, EGFR. KRAS,NRAS ,BRAF) mutations and Monitoring of disease progression.
• Validation and standardization of new diagnostic assays
• Quality control and assurance for diagnostic laboratory operations
• Joint research projects with universities, pharma, and biotech firms
• Custom assay development for infectious disease and oncology diagnostics
• Grant writing and funding support for diagnostic innovations
• On Demand Hands-on workshops on molecular diagnostics, PCR, RT-PCR and bioinformatics
• AI in healthcare training for pathologists and researchers
• Capacity-building programs for healthcare professionals and students